The importance of the pituitary adenylate-cyclase activating peptide (PACAP) is well established in migraine [140] and an ongoing phase 2 study is testing the efficacy of a PAC1 receptor antibody for migraine prevention [225]. The gene discussed is ADCYAP1R1; the disease is migraine disorder.